A clinical study of HMME-PDT therapy in Chinese pediatric patients with port-wine stain

Photodiagnosis Photodyn Ther. 2018 Sep:23:102-105. doi: 10.1016/j.pdpdt.2018.06.006. Epub 2018 Jun 8.

Abstract

Objective: To report our observations from a trial of the effectiveness and safety of hematoporphyrin monomethyl ether photodynamic therapy (HMME-PDT) in treating Chinese Pediatric patients port-wine stains (PWS).

Method: From October 2017 to December 2017, the study recruited 82 patients of PWS with negative HMME skin test results. The patients received an intravenous injection of 5 mg/kg HMME and the affected areas were exposed to 532 nm LED green light, with the irradiation power density between 80-85 mW/cm2. Each light spot was irradiated for 20-25 min. After two treatments, the clinical efficacy and posttreatment reactions at each treated area were observed.

Result: The patient age between 1 and 14 years old. 24 of the 82 cases were cured (29.27%) after two HMME-PDT treatment, 34 cases indicates a good efficacy (41.46%), 16 cases showed alleviation (19.51%), while 8 cases displayed no efficacy (9.76%). Pain was observed during treatment, and post-treatment edema was observed at the treated areas. No other obvious systematic adverse reaction were reported.

Conclusion: HMME-PDT is an effective and safe treatment for pediatric patients with PWS.

Keywords: Chinese pediatric patients; Hematoporphyrin monomethyl ether; Photodynamic therapy; Port-wine stain.

Publication types

  • Clinical Trial

MeSH terms

  • Adolescent
  • Child
  • Child, Preschool
  • Female
  • Hematoporphyrins / administration & dosage*
  • Humans
  • Infant
  • Male
  • Photochemotherapy / adverse effects
  • Photochemotherapy / methods*
  • Photosensitizing Agents / administration & dosage*
  • Port-Wine Stain / drug therapy*

Substances

  • Hematoporphyrins
  • Photosensitizing Agents
  • hematoporphyrin monomethyl ether